filings.toolsItem 16. Form 10-K Summary:
7K characters. Original on sec.gov · Markdown
Item 16. Form 10-K Summary:
None.
1 of 2
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| INTERNATIONAL BUSINESS MACHINES CORPORATION (Registrant) | ||||||||
| By: | /s/ NICOLÁS A. FEHRING | |||||||
| Nicolás A. Fehring | ||||||||
| Vice President and Controller | ||||||||
| (Chief Accounting Officer) | ||||||||
| Date: February 24, 2026 |
Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
| Signature | Title | Date | ||||||||||||
| /s/ ARVIND KRISHNA | Chairman of the Board, President and Chief Executive Officer | February 24, 2026 | ||||||||||||
| Arvind Krishna | ||||||||||||||
| /s/ JAMES J. KAVANAUGH | Senior Vice President, Finance and Operations, and Chief Financial Officer | February 24, 2026 | ||||||||||||
| James J. Kavanaugh | ||||||||||||||
| /s/ NICOLÁS A. FEHRING | Vice President and Controller (Chief Accounting Officer) | February 24, 2026 | ||||||||||||
| Nicolás A. Fehring |
2 of 2
Board of Directors
| By: | /s/ JANE P. EDWARDS | ||||||||||
| Jane P. Edwards | |||||||||||
| Marianne C. Brown | Director | Attorney-in-fact February 24, 2026 | |||||||||
| Thomas Buberl | Director | ||||||||||
| David N. Farr | Director | ||||||||||
| Alex Gorsky | Director | ||||||||||
| Michelle J. Howard | Director | ||||||||||
| Andrew N. Liveris | Director | ||||||||||
| F. William McNabb III | Director | ||||||||||
| Michael Miebach | Director | ||||||||||
| Martha E. Pollack | Director | ||||||||||
| Peter R. Voser | Director | ||||||||||
| Frederick H. Waddell | Director | ||||||||||
| Alfred W. Zollar | Director |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ON FINANCIAL STATEMENT SCHEDULE
To the Board of Directors and Stockholders of
International Business Machines Corporation:
Our audits of the consolidated financial statements referred to in our report dated February 24, 2026 appearing in the 2025 Annual Report to Stockholders of International Business Machines Corporation (which report and consolidated financial statements are incorporated by reference in this Annual Report on Form 10-K) also included an audit of the financial statement schedule listed in Item 15(a)(2) of this Form 10-K. In our opinion, this financial statement schedule presents fairly, in all material respects, the information set forth therein when read in conjunction with the related consolidated financial statements.
/s/ PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP
New York, New York
February 24, 2026
SCHEDULE II
INTERNATIONAL BUSINESS MACHINES CORPORATION AND SUBSIDIARY COMPANIES
VALUATION AND QUALIFYING ACCOUNTS AND RESERVES
For the Years Ended December 31:
(Dollars in Millions)
| Description | Balance at Beginning of Period | Balance at End of Period | ||||||||||||||||||||||||||||||
| Allowance For Credit Losses (1) | ||||||||||||||||||||||||||||||||
| 2025 | $ | 273 | $ | 276 | ||||||||||||||||||||||||||||
| 2024 | $ | 457 | $ | 273 | ||||||||||||||||||||||||||||
| 2023 | $ | 495 | $ | 457 | ||||||||||||||||||||||||||||
| Allowance For Inventory Losses | ||||||||||||||||||||||||||||||||
| 2025 | $ | 577 | $ | 535 | ||||||||||||||||||||||||||||
| 2024 | $ | 658 | $ | 577 | ||||||||||||||||||||||||||||
| 2023 | $ | 631 | $ | 658 | ||||||||||||||||||||||||||||
| Revenue Based Provisions | ||||||||||||||||||||||||||||||||
| 2025 | $ | 298 | $ | 388 | ||||||||||||||||||||||||||||
| 2024 | $ | 480 | $ | 298 | ||||||||||||||||||||||||||||
| 2023 | $ | 424 | $ | 480 |
(1) The majority of the write-offs during the period related to receivables which had been previously reserved.
Additions/deductions and write-offs for allowances and Revenue Based Provisions were not material for any of the periods presented.
S-1
Previous: Item 15. Exhibits, Financial Statement Schedules: